🇺🇸 FDA
Pipeline program

PTH

N01 AR92245

Phase 2 small_molecule completed

Quick answer

PTH for Osteoporosis is a Phase 2 program (small_molecule) at Black Diamond Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Black Diamond Therapeutics
Indication
Osteoporosis
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials